Unima Revenue and Competitors
Estimated Revenue & Valuation
- Unima's estimated annual revenue is currently $2.5M per year.
- Unima's estimated revenue per employee is $155,000
Employee Data
- Unima has 16 Employees.
- Unima grew their employee count by 7% last year.
Unima's People
| Name | Title | Email/Phone |
|---|
Unima Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Unima?
Unima develops fast and low cost diagnostic and disease surveillance technologies to solve the problem of lack of access to a timely diagnostic for 3 billion people living in the developing world or in low resource settings in high income countries.
keywords:N/A
N/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Unima News
... all the shows they perform and have received three Citations of Excellence from UNIMA-USA, the highest national award in puppetry.
... all the shows they perform and have received three Citations of Excellence from UNIMA-USA, the highest national award in puppetry.
... Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Nireus Aquaculture S.A., Tassal group Ltd., Nireus S.A., Unima Group.
... Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Nireus Aquaculture S.A., Tassal group Ltd., Nireus S.A., Unima Group.
Other Companies in Zapopan
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.5M | 16 | 7% | N/A |
#2 | $3.3M | 21 | -9% | N/A |
#3 | $2.2M | 24 | -8% | N/A |
#4 | $6.6M | 29 | -9% | $192.3M |
#5 | $14.9M | 57 | 33% | N/A |